{"case_id": "high_risk_polypharmacy", "mini_chart": "Patient: 68F, CHF, CKD stage 3\nQTc=520 ms; HR=52\nK=3.1; Mg=1.6\nMeds: ondansetron PRN, azithromycin, citalopram, furosemide, metoprolol\nContext: nausea/vomiting, diuresis, dehydration\n", "output": {"risk_summary": "- The patient has a prolonged QT interval (QTc=520 ms), which increases the risk of Torsades de Pointes (TdP).\n- The patient has hypokalemia (K=3.1 mEq/L) and hypomagnesemia (Mg=1.6 mg/dL), both of which can exacerbate QT prolongation and increase TdP risk.\n- The patient is taking medications known to prolong the QT interval, including ondansetron, azithromycin, and citalopram.\n- The patient's heart rate is low (HR=52 bpm), which can be associated with bradycardia and potentially worsen QT prolongation.\n- The patient has CHF and CKD, which can affect electrolyte balance and medication metabolism.", "action_plan": ["Obtain electrolyte repletion targets: Potassium (K) target 4.0-5.0 mEq/L, Magnesium (Mg) target 1.8-2.5 mg/dL.", "Replete electrolytes: Hold ondansetron, azithromycin, citalopram. Hold furosemide. Hold metoprolol.", "Repeat ECG recheck: Within 1 hour.", "Hold: Avoid adding any additional QT-prolonging agents; consider non-QT alternatives where feasible.", "Monitor: Continuous telemetry/escalation trigger: HR < 40 bpm or symptomatic bradycardia.", "Consult: Cardiology for potential med alternatives (e.g., antihistamine for nausea, different antibiotic, SSRI alternative) and further risk stratification."], "patient_counseling": "We need to correct your low potassium and magnesium levels to help protect your heart rhythm.\nWe will monitor your heart rate closely and restart medications safely once your levels are stable.\nPlease report any dizziness, palpitations, or fainting immediately.", "audit_view": {"missing_data": [], "notes": ["Inputs used: QTc=520 ms, K=3.1, Mg=1.6, ondansetron, azithromycin, citalopram, furosemide, metoprolol, HR=52.", "Decision support: QT interval prolongation risk assessment based on QTc, K, Mg, and medication review.", "Action plan generated based on risk assessment and patient factors."]}}}
{"case_id": "missing_data_deferral", "mini_chart": "Patient: 44M\nMeds: ondansetron PRN, azithromycin\nContext: nausea, palpitations\n", "output": {"risk_summary": "- QT risk cannot be graded safely because QTc and electrolytes are not provided.", "action_plan": ["Obtain ECG/QTc.", "Obtain serum potassium (K) and magnesium (Mg).", "Reassess QT-prolongation risk after results are available."], "patient_counseling": "To assess heart-rhythm risk safely, your care team needs an ECG and electrolyte lab results.", "audit_view": {"missing_data": [], "notes": ["MISSING_DATA: QTc, Potassium (K), Magnesium (Mg)", "Guardrail override: missing inputs; do not fabricate values.", "This output is decision support only."]}}}
